The global nanobodies market was valued at USD 132.2 million in 2020 and is expected to reach USD 9,192.0 million by the year 2028. Nanobodies also known as single-domain antibodies are a type of antibody fragment that consists of a single monomeric variable antibody domain. It contains unique structural and functional properties of naturally occurring heavy chain only antibodies.